Life Sciences Growth in 2025 – Why Your QA and Validation Teams Need to Scale Now
CMMI 3.0 Explained: Webinar Recording on Maturity Levels, Key Practices, and ROI
July 11, 2025
The life sciences industry is heading into a high-growth, high-stakes era. And the pressure to deliver has never been higher.
According to Deloitte’s latest executive outlook, nearly 70% of life sciences leaders anticipate revenue growth this year, despite mounting pressure around drug pricing, speed to market, and access to care. At the same time, companies are doubling down on innovation. Investing in things like AI, digital twins, and cloud platforms to accelerate development and gain a competitive edge.
This mix of growth, complexity, and regulation is putting QA and validation teams at the center of it all.
Pricing Pressure Is Driving R&D Productivity and QA/Validation Plays a Key Role
Deloitte’s research highlights pricing and access to drugs and medical devices as the #1 pressure facing the industry in 2025. The most common strategic action they’re taking? Investing in R&D productivity.
That’s where QA and validation can be a strategic advantage.
Whether it’s qualifying digital platforms, validating AI-powered systems, or managing risk-based approaches to process change, QA and validation teams help reduce delays, ensure quality, and speed up time-to-market.
In other words, better validation = better R&D output = improved efficiency and stronger market competitiveness.
Innovation Is Speeding Up. Validation Must Keep Pace
Generative AI. Digital twins. Smart factories. The tools driving the next wave of life sciences innovation are powerful, but they add complexity.
- AI in R&D requires validation of algorithms and workflows.
- Digital twins must be qualified as part of modeling or predictive testing.
- Cloud-based platforms must be validated for security, accuracy, and compliance.
And as Deloitte’s data shows, nearly a third of executives are already investing in these technologies at scale.
This transition takes time. And the time to start is now.
Scaling Smart: It’s Not Just About Headcount. It’s Strategic.
Scaling QA and validation doesn’t always mean hiring dozens of new people. It means building a strategy that flexes with your business:
- Hiring validation professionals familiar with AI/ML, digital platforms, ISO 13485, and relevant regulatory requirements in general
- Bringing in project-based resources to meet deadlines without overloading internal teams
- Leveraging experienced partners to optimize documentation, execution, and audit prep
You’re Innovating Fast. We’ll Help You Stay Ahead.
You’ve got new products in the pipeline, evolving regulations on the horizon, and pressure to move faster without sacrificing quality. That’s a lot to juggle. And your validation and QA teams are right in the thick of it.
At Theoris, we help life sciences teams like yours scale wisely. Whether you need extra hands to meet a critical deadline or long-term support to modernize your validation approach, we’ll roll up our sleeves and help you get it done (without slowing you down). Explore more of our quality and validation staffing services.
Reach out today and let’s build something that works now and sets you up for what’s next.
